相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2014)
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
Nicola De Stefano et al.
CNS DRUGS (2014)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
Maria Pia Sormani et al.
LANCET NEUROLOGY (2013)
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis
Maria Pia Sormani et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis
M. P. Sormani et al.
NEUROLOGY (2011)
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis
A. Prinster et al.
MULTIPLE SCLEROSIS (2010)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
Massimiliano Calabrese et al.
ARCHIVES OF NEUROLOGY (2009)
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Volker Brinkmann
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Gray matter atrophy in multiple sclerosis: A longitudinal study
Elizabeth Fisher et al.
ANNALS OF NEUROLOGY (2008)
Brain volume decline in aging
Anthony F. Fotenos et al.
ARCHIVES OF NEUROLOGY (2008)
Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
A. Minneboo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Brain Atrophy Assessment in Multiple Sclerosis: Importance and Limitations
Antonio Giorgio et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2008)
Brain atrophy in multiple sclerosis: what we know and would like to know
J. H. Simon
MULTIPLE SCLEROSIS JOURNAL (2006)
The measurement and clinical relevance of brain atrophy in multiple sclerosis
RA Bermel et al.
LANCET NEUROLOGY (2006)
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis
M Filippi et al.
BRAIN (2003)
Randomized, comparative study of interferon β-1a treatment regimens in MS -: The EVIDENCE trial
H Panitch et al.
NEUROLOGY (2002)
Normalized accurate measurement of longitudinal brain change
SM Smith et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2001)
分享论文
